Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical) has announced the addition of the "Biopharmaceutical Bioseparation Systems - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 52 companies including many key and niche players such as:
- 3M Company (US)
- 3M Purification, Inc. (US)
- Agilent Technologies, Inc. (US)
- Alfa Wassermann Separation Technologies, LLC (US)
- Flottweg Separation Technology (US)
- GEA Westfalia Separator Group GmbH (Germany)
- GE Healthcare (UK)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- Konik Nanobiotech SL (Spain)
- Merck KGaA (Germany)
- NuSep Holdings Ltd. (Australia)
- Pall Corporation (US)
- ProMetic Life Sciences, Inc. (Canada)
- Sartorius Stedim Biotech (France)
- Spectrum Laboratories, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Tosoh Bioscience, Inc. (Japan)
- YMC Europe GmbH (Germany)
Key Topics Covered:
1. Outlook
2. Industry Overview
3. Bioseparation Technologies - Key Trends
4. Product Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (32)
- Canada (1)
- Japan (5)
- Europe (18)
- - France (3)
- - Germany (9)
- - The United Kingdom (1)
- - Spain (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
Alphabet Replaces Verizon in Dow Jones Industrial Average
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 



